What does Cybozu do?
Cybozu provides cloud software that helps companies run internal communication and daily operations. Cybozu Office and Garoon are groupware products used for scheduling, workflow, and internal coordination. kintone is a no-code platform that lets business teams build and run internal apps without writing software, and revenue per customer rises as usage expands and accounts move to higher plans. What matters now is whether kintone ARPA can keep rising, how clearly management defines capital discipline for US investment, and whether buybacks and broader capital policy become a continuing framework.
What has driven the stock over the past two years?
kintone growth held up while US spending and cash policy weighed.
01 · THE RALLY Cybozu is a Japanese software company that, for most of its 28-year history, was known domestically as the maker of two groupware products — Cybozu Office for small and mid-size businesses and Garoon for larger organizations. Both ran for years as packaged on-premise software and gradually migrated to a subscription model on Cybozu's own cloud platform, cybozu.com. What changed the equity story was the platform's third application, launched in 2011: kintone, a no-code environment in which a non-technical employee inside a customer company can assemble database-backed business applications without writing software.
02 · THE REVERSAL The reversal began on December 18, 2025, when Cybozu published its initial guidance for FY12/26. Revenue was guided at +12.7% and OP at +4.1% — a collapse from the +106% just printed. The deeper question the disclosure raised, however, was structural: had the FY24/FY12/25 ARPA step from ¥34,100 in FY12/23 to ¥47,100 in FY12/25 been a repeatable pricing lever, or a one-time event the company had already absorbed?
03 · WHERE WE STAND NOW Two disclosures landed after the market close on May 14, 2026. The 1Q FY12/26 tanshin printed revenue ¥10,246M (+17.0% YoY), OP ¥3,014M (+15.3% YoY), and net income ¥2,191M (+21.6% YoY). The 15% OP growth was achieved at the higher cost base the FY12/26 plan had already embedded: ad spend up 28% in the quarter, R&D up 34%, with Ehime Sports operating cost now consolidated in cost of sales.
What has to be verified next?
ARPA, overseas investment, and capital returns now shape the multiple.
- The May 14 first quarter supports a conservative reading of the 4.1% full-year OP guide. Margin reached 29.4%, well above the 24.9% assumed for the year.
- FY12/25 profit benefited from a major price revision. Cybozu has not said whether it can repeat an increase of similar size, so investors should not treat the same margin lift as recurring.
- Large SaaS companies often spend years building a US market before they turn profitable. Cybozu can afford patience because it has no debt and generated ¥10.7bn of operating cash in FY12/25.
- Cybozu has committed about ¥11.5bn of equity to the US subsidiary without disclosing a payback milestone. That makes patience indistinguishable from sunk-cost behavior from the outside.
- The May 14 buyback is large enough to mark a change in capital allocation if it becomes repeatable. A stated rule for future purchases would separate a new policy from a one-off decision.
- Founder-CEO Aono still concentrates capital-allocation decisions and has supported the US business through years of losses. His 17% holding aligns him with shareholders, but it also reduces the pressure to set an external deadline.
What could change over the next twelve months?
Three actions could clarify growth quality and capital discipline.
- The reported 121.9% NRR combines higher prices with customers adding seats and products. Breaking kintone ARPA into price, seats, and tier would show how much growth comes from each source and whether it can continue after the current price increase is fully reflected.
- Cybozu's buyback is currently a one-off. Tying future purchases to a stated valuation hurdle, employee-stock dilution, or a defined share of net income would tell shareholders when excess cash will be returned instead of leaving each decision to the board.
- The US subsidiary remains Cybozu's largest capital-allocation question. Publishing the capital committed to Kintone Corp, the revenue or profit milestone that justifies more funding, and a payback timetable would let investors judge whether overseas investment is creating value.
What could the shares be worth over the next four quarters?
The range depends on kintone growth, overseas losses, and capital returns.
The bear band of ¥1,500–¥1,800 implies ~5.8–7.0x forward EV/OP — below the 7–10x range typical of JP private-buyer transactions. The bear is multiple-driven only if the market continues to discount pricing-power durability beyond what a strategic buyer would.
The bull peak of ¥4,000 stays below the August 2025 high of ¥4,150 — the range does not assume a return to the peak ~30x forward EV/OP multiple, which would require both ARPA re-acceleration and the US/APAC business turning a structural corner, two-stage optionality outside this four-quarter scenario.
This is not investment advice.
Japan Investor Interface Co., Ltd. ("JII") is an investor-relations (IR) consultancy. JII is not a registered investment advisor, financial advisor, broker-dealer, or securities firm in any jurisdiction. JII is not registered as a Financial Instruments Business Operator (金融商品取引業者) under Japan's Financial Instruments and Exchange Act. JII does not have a 投資助言・代理業 registration and does not provide investment advice or solicit the purchase, sale, or holding of any security.
JII Compounders is an editorial publication. Each profile is an analytical study of how publicly disclosed information about a Japanese listed company has been received by the market. It is intended for educational and research purposes for IR professionals, finance students, journalists, and other readers interested in corporate disclosure practice. Nothing in this publication constitutes a recommendation, opinion, suggestion, or solicitation to buy, sell, or hold any security, derivative, or other financial instrument. Price targets, scenario ranges, multiples, and comparable-company references are illustrative of analytical method only and must not be interpreted as JII's investment opinion.
No reliance. The information presented may be incomplete, out of date, or incorrect. Forward-looking statements are inherently uncertain. Past price performance does not indicate future results. Estimates and scenario figures are not predictions and may not be achieved. JII makes no representation or warranty, express or implied, regarding the accuracy, completeness, timeliness, or reliability of any information in this publication.
No fiduciary or advisory relationship. Reading this publication does not create any advisory, fiduciary, or professional relationship between you and JII. Before making any investment, tax, accounting, legal, or other decision, you should consult qualified, licensed advisors in your jurisdiction and conduct your own independent due diligence based on primary disclosures issued by the company concerned.
Trademarks & data. Company names, logos, tickers, and product names referenced are the property of their respective owners. Share-price data is licensed from third-party providers. TradingView is a trademark of TradingView, Inc. All rights reserved.
Conflicts of interest. JII, its officers, and related parties do not hold or trade securities of companies covered in JII research. If JII has a paid engagement with a company covered in a publication, that relationship is disclosed in the relevant publication. JII's publications are for informational purposes only and do not constitute investment advice or a recommendation to buy or sell any security.
本資料は、日本の金融商品取引法に基づく投資助言・代理業ではなく、特定の有価証券の売買その他の取引の勧誘・推奨を目的とするものではありません。本資料は教育・研究を目的とした分析記事であり、JII（株式会社ジャパン・インベスター・インターフェース）は、本資料の内容に基づく投資判断について一切の責任を負いません。投資の判断はご自身の責任と独立した調査に基づいて行ってください。